Surrozen (SRZN) EBIT Margin (2020 - 2026)
Surrozen's EBIT Margin was -207.40% in Q2 2026, up 709.89 percentage points from -917.29% a year earlier and up 1.72 percentage points from the prior quarter.
Powered by 
Analysis
Surrozen (SRZN) EBIT Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Surrozen's EBIT Margin was -385.28% through Jun 30, 2026, down 179.85 percentage points year-over-year; for FY2025, it came in at -1210.58%, down 970.89 percentage points from FY2024.
- EBIT Margin shows a three-year change of -855.87 percentage points (FY2022 to FY2025).
- In earlier years, EBIT Margin was -239.69% in FY2024 and -354.71% in FY2022.
- The Q2 2026 figure marks the highest quarterly EBIT Margin since Q3 2024.
- Compared with a year earlier, EBIT Margin was higher in two of the last four quarters, with an average year-over-year change of -182.31 percentage points.
- Per Business Quant data, SRZN's EBIT Margin in the three quarters before Q2 2026 was -209.12% (Q1 2026), -2393.75% (Q4 2025) and -1107.32% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.06 Bn | 1,102.65 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 616.49 Bn | 535.01 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 501.55 Bn | 474.66 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 367.24 Bn | 321.62 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.48 Bn | 235.17 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 236.17 Bn | 191.57 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 190.68 Bn | 164.87 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 169.35 Bn | 115.99 Bn | 10.94 Bn | 28.37% |
| 10 | Surrozen | 294.61 Mn | -84.92 Mn | - | -207.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -207.40% |
| Mar 31, 2026 | -209.12% |
| Dec 31, 2025 | -2,393.75% |
| Sep 30, 2025 | -1,107.32% |
| Jun 30, 2025 | -917.29% |
| Mar 31, 2025 | -971.62% |
| Dec 31, 2024 | -1,311.76% |
| Sep 30, 2024 | 12.32% |
| Sep 30, 2021 | -97,892.86% |
| Sep 30, 2020 | -144,016.67% |
API Access
Surrozen EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=SRZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "SRZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=SRZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();